My Profile
James Pethokoukis
Where politics and the economy intersect.
See all posts
Tue 24 Nov 2009 | 18:24 EST
You are here:
Home
>
Business & Finance
>
Stocks
> Officers and Directors
Home
Business & Finance
Markets
Deals
Small Business
Green Business
Industries
Industry Summits
Stocks
Advanced Stock Search
Overview
Option Quote
Chart
Officers and Directors
Key Developments
Company News
Press Releases
Financial Highlights
Ratios
Financial Statements
Performance
Insider Trading
Institutional Holders
Estimates
Recommendations
Analyst Research
Funds
ETFs
Currencies
Commodities
Options
Economy
Bonds
Analyst Research
Portfolio
News
Do More With Reuters
RSS
Widgets
Mobile
Podcasts
Newsletters
Your View
Make Reuters My Homepage
Partner Services
CareerBuilder
Affiliate Network
Professional Products
Support (Customer Zone)
Reuters Media
Financial Products
About Thomson Reuters
Officers and Directors For Genetic Technologies Limited
Genetic Technologies Limited (GENE.O) (Consolidated Issue listed on NASDAQ Global Market)
sector:
Healthcare
.
industry:
Biotechnology
ยท
View
GENE
on other exchanges
As of 23 Nov 2009
1.44
USD
Price Change
+0.13
Percent Change
+10.26%
Analyst Recommendations
Research Another Stock:
Symbol Look-up
Independent Research
|
Broker Research
Summary
Biographies
Basic Compensation
Options Compensation
Name
Age
Since
Current Position
Jones, Huw
46
2008
Non-Executive Independent Director
Hack, Sidney
71
2008
Non-Executive Independent Director
Brandon, Malcolm
57
2009
Non-Executive Director
Bart, Fred
54
2008
Non-Executive Chairman of the Board
Ashdown, M. Luisa
--
2009
Interim Chief Operating Officer
Howitt, Thomas
45
2009
Chief Financial Officer, Company Secretary
MacLeman, Paul
43
2009
Chief Executive Officer
Find out more about GENE.O
Insider Trading